These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 9346339

  • 21. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q, Bhat M, Bowen WD, Cheng J.
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP, Michaud JC, Le Fur G, Soubrié P.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
    [Abstract] [Full Text] [Related]

  • 23. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM, Paria BC, Dey SK.
    Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor.
    Ruiu S, Pinna GA, Marchese G, Mussinu JM, Saba P, Tambaro S, Casti P, Vargiu R, Pani L.
    J Pharmacol Exp Ther; 2003 Jul; 306(1):363-70. PubMed ID: 12663689
    [Abstract] [Full Text] [Related]

  • 25. delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.
    Burkey TH, Quock RM, Consroe P, Roeske WR, Yamamura HI.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):R3-4. PubMed ID: 9128853
    [Abstract] [Full Text] [Related]

  • 26. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.
    Nieri P, Martinotti E, Testai L, Adinolfi B, Calderone V, Breschi MC.
    Eur J Pharmacol; 2003 Jan 10; 459(1):75-81. PubMed ID: 12505536
    [Abstract] [Full Text] [Related]

  • 27. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
    Izzo AA, Mascolo N, Capasso R, Germanò MP, De Pasquale R, Capasso F.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug 10; 360(2):221-3. PubMed ID: 10494894
    [Abstract] [Full Text] [Related]

  • 28. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.
    Antonelli T, Tanganelli S, Tomasini MC, Finetti S, Trabace L, Steardo L, Sabino V, Carratu MR, Cuomo V, Ferraro L.
    Neuroscience; 2004 Aug 10; 124(2):367-75. PubMed ID: 14980386
    [Abstract] [Full Text] [Related]

  • 29. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
    de Novellis V, Mariani L, Palazzo E, Vita D, Marabese I, Scafuro M, Rossi F, Maione S.
    Neuroscience; 2005 Aug 10; 134(1):269-81. PubMed ID: 15953687
    [Abstract] [Full Text] [Related]

  • 30. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
    Hoffman AF, Oz M, Caulder T, Lupica CR.
    J Neurosci; 2003 Jun 15; 23(12):4815-20. PubMed ID: 12832502
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K, Molleman A, Parsons M, Whelan C.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):207-15. PubMed ID: 12620515
    [Abstract] [Full Text] [Related]

  • 32. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
    Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ.
    Eur J Pharmacol; 2001 Sep 28; 428(1):51-7. PubMed ID: 11779037
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
    Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME.
    Eur J Pharmacol; 1999 Jul 14; 377(1):117-25. PubMed ID: 10448934
    [Abstract] [Full Text] [Related]

  • 34. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.
    Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L.
    Eur J Pharmacol; 2002 Aug 16; 450(1):77-83. PubMed ID: 12176112
    [Abstract] [Full Text] [Related]

  • 35. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG.
    Br J Pharmacol; 1999 Feb 16; 126(3):665-72. PubMed ID: 10188977
    [Abstract] [Full Text] [Related]

  • 36. Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia.
    Richter A, Löscher W.
    Eur J Pharmacol; 2002 Nov 15; 454(2-3):145-51. PubMed ID: 12421641
    [Abstract] [Full Text] [Related]

  • 37. Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [(3)H]CP55940 and [(3)H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release.
    Dhopeshwarkar AS, Nicholson RA.
    Eur J Pharmacol; 2014 Jan 15; 723():431-41. PubMed ID: 24211785
    [Abstract] [Full Text] [Related]

  • 38. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
    Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R.
    Eur J Pharmacol; 2003 Feb 07; 461(1):27-34. PubMed ID: 12568912
    [Abstract] [Full Text] [Related]

  • 39. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury.
    Kim SH, Won SJ, Mao XO, Jin K, Greenberg DA.
    J Pharmacol Exp Ther; 2005 Apr 07; 313(1):88-94. PubMed ID: 15626718
    [Abstract] [Full Text] [Related]

  • 40. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands.
    Smith SR, Terminelli C, Denhardt G.
    Eur J Pharmacol; 2001 Aug 03; 425(1):73-83. PubMed ID: 11672577
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.